Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Enochian Shares Trade Up 50% upon Concluding FDA Meeting for Potential HIV Cure

Shares of Enochian Biosciences reached a new 52-week high after the company reported that it successfully completed its FDA INTERACT meeting for ENOB-HV-01, a potential cure for HIV. Gene-modified cellular and immune therapies company Enochian Biosciences Inc. (EN...
Streetwise Reports | June 9, 2020 |

Star Navigation: Bridging the gap between flight experience and flight safety in real-time

Star Navigation bridges the gap between flight experience and flight safety in real time. When it comes to the aerospace industry, the Ontario-based leading-edge technology company offers both hardware and software solutions. The company’s real-time ca...
Simon Druker | November 2, 2022 |

Fibrocell Science Shares Rise 60% on Acquisition News

Fibrocell Science's shares are trading up 60% today after the company announced that it agreed to be acquired by Castle Creek Holdings for $63.3 million, or $3.00 per share. Cell and gene therapy company Fibrocell Science Inc. (FCSC:NASDAQ) , which focuses on transfo...
Streetwise Reports | September 16, 2019 |

EyeGate Pharma Shares Looking Up on Pivotal PRK Ocular Bandage Gel Study Data

EyeGate Pharmaceuticals shares opened nearly 85% higher today after the company reported select topline data demonstrating that it met its primary endpoint in its cornea wound repairs pivotal photorefractive keratectomy study using the firm's Ocular Bandage Gel eye drop. ...
Streetwise Reports | November 25, 2019 |

Supercharge Your Gold Position With Precious Metal Royalty Companies

Gold closed down as much as 1.21 percent Friday on a blowout jobs report that seemed to alleviate investor fears of an impending economic slowdown. The U.S. added as many as 266,000 jobs in November, beating expectations of 180,000, while the unemployment rate ticked do...
Frank Holmes | December 9, 2019 |

“Buy-and-Hold” Has Historically Been a Winning Investment Strategy

I don’t believe it’s an exaggeration to say that 2019 exceeded expectations for a great number of investors. The S&P 500 Index increased more than 31 percent, putting last year among the very best going all the way back to 1928. Since the...
Frank Holmes | January 16, 2020 |

New Beginnings With the Year of the Rat

Saturday marked the Chinese Lunar New Year, a time when as many as 400 million people ordinarily travel to visit family and go on vacation. Before the coronavirus struck, 3 billion trips were estimated to take place during the 16-day celebration, while some 79 million p...
Frank Holmes | January 27, 2020 |

Regeneron Shares Rise 10% on Advances in its Novel COVID-19 Antibody Program

Shares of Regeneron Pharmaceuticals rose to a new 52-week high price after the company reported it has identified hundreds of virus-neutralizing antibodies and plans to initiate large-scale manufacturing by mid-April of a multi-antibody therapy to treat coronavirus. ...
Streetwise Reports | March 18, 2020 |

Gold Mining Stocks Flip from Losses to 5x Leveraged Gains!

The gold price made a new 2020 high today and looks poised to take out the nominal all-time high around $1,920 and then challenge $2,000 in the months ahead. Some are even estimating that gold could climb to $3,000 by year-end on account of the nearly $10 trillion in new mon...
Jason Hamlin | May 19, 2020 |

Fibonacci Price Modeling Suggests Massive Resistance Range In US Markets

The big selloff in the US markets last week (-1600 pts in the Dow Jones) on the comments from the US Fed aligns with previous Fibonacci Price Trigger levels throughout the early portion of 2020 to create a massive Support/Resistance range in the markets according to our rese...
Chris Vermeulen | June 17, 2020 |
1 2 3 4